These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20103549)

  • 41. Glitazones and the cardiovascular system.
    Devchand PR
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):188-92. PubMed ID: 18316956
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pioglitazone versus rosiglitazone treatment in patients with type 2 diabetes and dyslipidemia: cost-effectiveness in the US.
    Tunis SL; Minshall ME; St Charles M; Pandya BJ; Baran RW
    Curr Med Res Opin; 2008 Nov; 24(11):3085-96. PubMed ID: 18826750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pioglitazone insulin sensitivity and type 2 diabetes mellitus: recent data].
    Monnier L; Sauvanet JP
    Ann Endocrinol (Paris); 2004 Apr; 65(2):136-48. PubMed ID: 15247874
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thiazolidinediones and cardiovascular events in patients with type 2 diabetes mellitus: a retrospective cohort study of over 473,000 patients using the National Health Insurance database in Taiwan.
    Hsiao FY; Huang WF; Wen YW; Chen PF; Kuo KN; Tsai YW
    Drug Saf; 2009; 32(8):675-90. PubMed ID: 19591532
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications.
    Krentz A
    Diabetes Metab Res Rev; 2009 Feb; 25(2):112-26. PubMed ID: 19219860
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of safety warnings and risk management plan for Thiazolidinediones in Taiwan.
    Hsu JC; Cheng CL; Ross-Degnan D; Wagner AK; Zhang F; Kao Yang YH; Liu LL; Tai HY; Chen KH; Yang PW; Lu CY
    Pharmacoepidemiol Drug Saf; 2015 Oct; 24(10):1026-35. PubMed ID: 26251229
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Case series of liver failure associated with rosiglitazone and pioglitazone.
    Floyd JS; Barbehenn E; Lurie P; Wolfe SM
    Pharmacoepidemiol Drug Saf; 2009 Dec; 18(12):1238-43. PubMed ID: 19623674
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The "glitazones": rosiglitazone and pioglitazone.
    Papoushek C
    J Obstet Gynaecol Can; 2003 Oct; 25(10):853-7. PubMed ID: 14532954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Incomplete Medicalization of Obesity: Physician Office Visits, Diagnoses, and Treatments, 1996-2014.
    Ciciurkaite G; Moloney ME; Brown RL
    Public Health Rep; 2019; 134(2):141-149. PubMed ID: 30794761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. National trends in the treatment of diabetic nephropathy in the United States.
    Ajiboye O; Segal JB
    J Clin Pharm Ther; 2017 Jun; 42(3):311-317. PubMed ID: 28295491
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Variation in use of broad-spectrum antibiotics for acute respiratory tract infection.
    Mainous AG; Hueston WJ
    JAMA; 2003 Jun; 289(21):2797; author reply 2797-8. PubMed ID: 12783910
    [No Abstract]   [Full Text] [Related]  

  • 52. Trends in antimicrobial drug prescribing among office-based physicians in the United States.
    McCaig LF; Hughes JM
    JAMA; 1995 Jan; 273(3):214-9. PubMed ID: 7807660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inappropriate medication prescribing for the elderly by office-based physicians.
    Aparasu RR; Fliginger SE
    Ann Pharmacother; 1997; 31(7-8):823-9. PubMed ID: 9220038
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of cholesterol-lowering medications in the United States from 1991 to 1997.
    Siegel D; Lopez J; Meier J
    Am J Med; 2000 Apr; 108(6):496-9. PubMed ID: 10781783
    [No Abstract]   [Full Text] [Related]  

  • 55. A population-based analysis of antidiabetic medications in four Canadian provinces: Secular trends and prescribing patterns.
    Secrest MH; Azoulay L; Dahl M; Clemens KK; Durand M; Hu N; Targownik L; Turin TC; Dormuth CR; Filion KB
    Pharmacoepidemiol Drug Saf; 2020 Jan; 29 Suppl 1():86-92. PubMed ID: 31464069
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Glitazones in type 2 diabetes: an update.
    Drug Ther Bull; 2008 Apr; 46(4):25-9. PubMed ID: 18403615
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Glitazone treatment of type 2 diabetes mellitus].
    Johansen OE; Jørgensen AP
    Tidsskr Nor Laegeforen; 2006 Aug; 126(15):1928-30. PubMed ID: 16915317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus?
    Consoli A; Formoso G
    Diabetes Obes Metab; 2013 Nov; 15(11):967-77. PubMed ID: 23522285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States.
    Stafford RS; Monti V; Furberg CD; Ma J
    Hypertension; 2006 Aug; 48(2):213-8. PubMed ID: 16785334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacologic therapy for type 2 diabetes mellitus.
    DeFronzo RA
    Ann Intern Med; 2000 Jul; 133(1):73-4. PubMed ID: 10877745
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.